The aim of the present systematic review and meta-analysis of observational studies was to gain further insight into the effects of adherence to Mediterranean Diet (MD) on overall cancer mortality, incidence of different types of cancer, and cancer mortality risk in cancer survivors.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Literature search was performed using the electronic databases PubMed, and EMBASE until 2 July 2015. We included either cohort (for specific tumors only incidence cases were used) or case-control studies. Study specific risk ratios, hazard ratios, and odds ratios (RR/HR/OR) were pooled using a random effect model. The updated review process showed 23 observational studies that were not included in the previous meta-analysis (total number of studies evaluated: 56 observational studies). An overall population of 1,784,404 subjects was included in the present update. The highest adherence score to an MD was significantly associated with a lower risk of all-cause cancer mortality (RR: 0. 87, 95% CI 0. 81-0. 93, I(2) = 84%), colorectal cancer (RR: 0. 83, 95% CI 0. 76-0. 89, I(2) = 56%), breast cancer (RR: 0. 93, 95% CI 0. 87-0. 99, I(2) =15%), gastric cancer (RR: 0. 73, 95% CI 0. 55-0. 97, I(2) = 66%), prostate cancer (RR: 0. 96, 95% CI 0. 92-1. 00, I(2) = 0%), liver cancer (RR: 0. 58, 95% CI 0. 46-0. 73, I(2) = 0%), head and neck cancer (RR: 0. 40, 95% CI 0. 24-0. 66, I(2) = 90%), pancreatic cancer (RR: 0. 48, 95% CI 0. 35-0. 66), and respiratory cancer (RR: 0. 10, 95% CI 0. 01-0. 70). No significant association could be observed for esophageal/ovarian/endometrial/and bladder cancer, respectively. Among cancer survivors, the association between the adherence to the highest MD category and risk of cancer mortality, and cancer recurrence was not statistically significant. The updated meta-analyses confirm a prominent and consistent inverse association provided by adherence to an MD in relation to cancer mortality and risk of several cancer types.
Cancer medicine. 2015 Oct 16 [Epub ahead of print]
Lukas Schwingshackl, Georg Hoffmann
Department of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, Althanstraße 14 UZA II, A-1090, Vienna, Austria. , Department of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, Althanstraße 14 UZA II, A-1090, Vienna, Austria.